The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib

被引：0
|
作者：
Warit Ruanglertboon
Michael J. Sorich
Jessica M. Logan
Andrew Rowland
Ashley M. Hopkins
机构：
[1] Flinders University,Department of Clinical Pharmacology, College of Medicine and Public Health
[2] University of South Australia,Mechanisms in Cell Biology and Disease Research Group, Clinical and Health Sciences, Cancer Research Institute
来源：
Journal of Cancer Research and Clinical Oncology | 2020年 / 146卷
关键词：
Sorafenib; Proton pump inhibitors; Prediction; Survival outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2693 / 2697
页数：4
相关论文
共 50 条
  • [31] Overall survival predictors in hepatocellular carcinoma patients treated with sorafenib
    da Costa Ferreira, Caroline Petersen
    Ribeiro, Mauricio Alves
    Szutan, Luiz Arnaldo
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (03): : 275 - 283
  • [32] Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
    Pinter, M.
    Sieghart, W.
    Hucke, F.
    Graziadei, I.
    Vogel, W.
    Maieron, A.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Matejka, J.
    Stauber, R.
    Buder, R.
    Gruenberger, B.
    Schoeniger-Hekele, M.
    Mueller, C.
    Peck-Radosavljevic, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 949 - 959
  • [33] Proton Pump Inhibitors, Prior Therapy and Survival in Patients Treated With Immune Checkpoint Inhibitors for Advanced NSCLC
    Husain, M.
    Xu, M.
    Patel, S.
    Johns, A.
    Grogan, M.
    Li, M.
    Lopez, G.
    Miah, A.
    Hoyd, R.
    Liu, Y.
    Muniak, M.
    Haddad, T.
    Tinoco, G.
    Kendra, K.
    Otterson, G.
    Presley, C.
    Spakowicz, D.
    Owen, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1076 - S1076
  • [34] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
  • [35] Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression
    Apostolidis, Leonidas
    Pfeiffenberger, Jan
    Gotthardt, Daniel
    Radeleff, Boris
    Mehrabi, Arianeb
    Schemmer, Peter
    Jaeger, Dirk
    Schirmacher, Peter
    Stremmel, Wolfgang
    Schulze-Bergkamen, Henning
    Springfeld, Christoph
    Weiss, Karl Heinz
    GASTROINTESTINAL TUMORS, 2018, 5 (1-2) : 38 - 46
  • [36] Doxorubicin and sorafenib improves survival in patients with advanced hepatocellular carcinoma
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2011, 8 (2) : 61 - 61
  • [37] Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based study
    Chu, Shou-Sheng
    Kuo, Yu-Hsuan
    Liu, Wen-Shan
    Wang, Shih-Chang
    Ho, Chung-Han
    Chen, Yi-Chen
    Yang, Ching-Chieh
    Wu, Hung-Chang
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] The impact of post-progression survival on overall survival of patients with advanced hepatocellular carcinoma treated by sorafenib therapy
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Arai, Kuniaki
    Kagaya, Takashi
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY, 2013, 58 : 1221A - 1221A
  • [39] Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Biselli, Maurizio
    Reggidori, Nicola
    Iavarone, Massimo
    Renzulli, Matteo
    Lani, Lorenzo
    Granito, Alessandro
    Piscaglia, Fabio
    Lorenzini, Stefania
    Alimenti, Eleonora
    Vara, Giulio
    Caraceni, Paolo
    Sangiovanni, Angelo
    Marignani, Massimo
    Gigante, Elia
    Brandi, Nicolo
    Gramenzi, Annagiulia
    Trevisani, Franco
    CANCERS, 2024, 16 (06)
  • [40] Sorafenib in advanced hepatocellular carcinoma
    Sauerbruch, T.
    Gonzalez-Carmona, A. M.
    Nitschmann, S.
    INTERNIST, 2009, 50 (11): : 1290 - 1292
12345